AI assistant
FendX Technologies — AGM Information 2023
May 19, 2023
48310_rns_2023-05-18_4fea8fd8-6365-415b-aac9-f96f87ba9570.pdf
AGM Information
Open in viewerOpens in your device viewer
FENDX TECHNOLOGIES INC. 2010 Winston Park Drive, 2[nd] Floor Oakville, ON L6H 5R7 Telephone: (800) 344‐9868
NOTICE OF ANNUAL GENERAL AND SPECIAL MEETING
TO THE SHAREHOLDERS:
NOTICE IS HEREBY GIVEN that the annual general and special meeting (the “ Meeting ”) of shareholders of FendX Technologies Inc. (the “ Company ”) will be held at the offices of Clark Wilson LLP, 900 – 885 West Georgia Street, Vancouver, BC, V6C 3H1 and via ZOOM at:
= https://us06web.zoom.us/j/83933364797?pwd OFhhdXRsMXg5VWVBK2YyNEl4Y1ZNZz09 Meeting ID: 839 3336 4797
Passcode: 120261 or find your local number at https://us06web.zoom.us/u/k248NMwcY
on Friday, June 16, 2023, at the hour of 11:00 a.m. (Vancouver time) for the following purposes:
-
(1) to receive the audited financial statements of the Company for the fiscal year ended December 31, 2022, and the accompanying report of the auditors;
-
(2) to set the number of directors of the Company at three (3);
-
(3) to elect Dr. Carolyn Myers, Stephen Randall and Pierre Soulard as directors of the Company;
-
(4) to appoint Dale Matheson Carr‐Hilton LaBonte LLP as the auditors of the Company for the fiscal year ending December 31, 2023 and to authorize the directors of the Company to fix the remuneration to be paid to the auditors for the fiscal year ending December 31, 2023;
-
(5) to consider and, if thought fit, to pass an ordinary resolution to ratify, confirm and approve the Company’s Equity Incentive Plan, as described in the accompanying information circular (the “ Information Circular ”); and
-
(6) to transact such further or other business as may properly come before the Meeting and any adjournment or postponement thereof.
The accompanying Information Circular provides additional information relating to the matters to be dealt with at the Meeting and is supplemental to, and expressly made a part of, this notice of Meeting (the “ Notice of Meeting ”).
The board of directors of the Company has fixed May 9, 2023 as the record date for the determination of shareholders entitled to notice of and to vote at the Meeting and at any adjournment or postponement thereof. Each registered shareholder at the close of business on that date is entitled to such notice and to vote at the Meeting in the circumstances set out in the accompanying Information Circular.
If you are a registered shareholder of the Company and unable to attend the Meeting in person, please vote by proxy by following the instructions provided in the form of proxy at least 48 hours (excluding Saturdays, Sundays and holidays recognized in the Province of British Columbia) before the time and date of the Meeting or any adjournment or postponement thereof.
In view of COVID‐19, the Company asks that, in considering whether to attend the Meeting in person, shareholders ‐ follow the instructions of the Public Health Agency of Canada (https://www.canada.ca/en/public
- 2 -
health/services/diseases/2019‐novel‐coronavirus‐infection.html). The Company encourages Shareholders not to attend the Meeting in person if experiencing any of the described COVID‐19 symptoms of fever, cough or difficulty breathing. The Company may take additional precautionary measures in relation to the Meeting in response to further developments in the COVID‐19 outbreak. As always, the Company encourages shareholders to vote prior to the Meeting. Shareholders are encouraged to vote on the matters before the meeting by proxy and to join the Meeting by teleconference.
If you are a non‐registered shareholder of the Company and received this Notice of Meeting and accompanying materials through a broker, a financial institution, a participant, or a trustee or administrator of a retirement savings plan, retirement income fund, education savings plan or other similar savings or investment plan registered under the Income Tax Act (Canada), or a nominee of any of the foregoing that holds your securities on your behalf (each, an “ Intermediary ”), please complete and return the materials in accordance with the instructions provided to you by your Intermediary.
DATED at Vancouver, British Columbia, this 16[th] day of May, 2023.
By Order of the Board of Directors of
FENDX TECHNOLOGIES INC.
“Dr. Carolyn Myers” Dr. Carolyn Myers President, Chief Executive Officer and Director